Glomerulonephritis is the most common cause of end stage renal disease between the age of five and 45. Remarkable advances have been made in recent years in our understanding of the causes of these diseases.
In addition, several new drugs have recently been approved by the FDA for the treatment of these diseases, and many other therapies are in active development.
The Glomerular Diseases Clinic was developed to integrate state-of-the-art clinical care, patient education, clinical trials, and basic research focused on the glomerular diseases.
The clinic treats all forms of glomerular disease, including IgA nephropathy, lupus nephritis, focal segmental glomerulosclerosis (FSGS), membranous nephropathy, ANCA-associated vasculitis, anti-GBM disease, and minimal change disease.
Our multidisciplinary team includes providers from nephrology, renal pathology, rheumatology, and immunology. Through this clinic, providers collaborate on clinical studies of new treatments for glomerular diseases and basic research studies into the causes of glomerulonephritis.
Educational activities include meetings for patients and their families, continuing educational forums for clinicians, scientific conferences, and scientific publications.